Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's disease.

Crohn's disease Inflammatory bowel diseases Lymphnodes Mesentery Postoperative complications Postoperative recurrence Surgery

Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 07 11 2020
revised: 25 06 2021
accepted: 29 06 2021
pubmed: 24 7 2021
medline: 6 5 2022
entrez: 23 7 2021
Statut: ppublish

Résumé

Mesentery thickening and enlarged lymphnodes are typical findings of Crohn's disease (CD), but their role is unknown. Aim of the present study was to evaluate their prevalence and significance on postoperative complications and long-term surgical recurrence after CD surgery. 1272 consecutive, unselected patients were retrospectively reviewed, divided into 4 groups based on the presence or absence of a thickened mesentery and enlarged lymphnodes, and stratified for primary or recurrent surgical procedure. In all patients but those treated with strictureplasty the mesentery and lymphnodes were removed. Patients' characteristics, peri-operative findings, and long-term recurrence were compared by univariate and multivariate analysis. Thickened mesentery and enlarged lymphnodes were not present in all cases, were typical of ileal location and penetrating behaviour, had a constant decrease over recurrences, were independent of either pre-operative medical therapy or surgical approach, did not increase the duration of surgery and complications, presented similar 20-years recurrence rate to normal mesentery and lymphnodes. Lymphopathy was associated to a worst nutritional status during disease recurrences. At multivariate analysis, age, location, and behaviour, but not mesenteric characteristics, were related to an increased risk of surgical recurrence. This study provides new information on mesentery and lymphnodes in CD patients. Further studies are needed to clarify the appropriate surgical approach.

Sections du résumé

BACKGROUND BACKGROUND
Mesentery thickening and enlarged lymphnodes are typical findings of Crohn's disease (CD), but their role is unknown. Aim of the present study was to evaluate their prevalence and significance on postoperative complications and long-term surgical recurrence after CD surgery.
METHODS METHODS
1272 consecutive, unselected patients were retrospectively reviewed, divided into 4 groups based on the presence or absence of a thickened mesentery and enlarged lymphnodes, and stratified for primary or recurrent surgical procedure. In all patients but those treated with strictureplasty the mesentery and lymphnodes were removed. Patients' characteristics, peri-operative findings, and long-term recurrence were compared by univariate and multivariate analysis.
RESULTS RESULTS
Thickened mesentery and enlarged lymphnodes were not present in all cases, were typical of ileal location and penetrating behaviour, had a constant decrease over recurrences, were independent of either pre-operative medical therapy or surgical approach, did not increase the duration of surgery and complications, presented similar 20-years recurrence rate to normal mesentery and lymphnodes. Lymphopathy was associated to a worst nutritional status during disease recurrences. At multivariate analysis, age, location, and behaviour, but not mesenteric characteristics, were related to an increased risk of surgical recurrence.
CONCLUSIONS CONCLUSIONS
This study provides new information on mesentery and lymphnodes in CD patients. Further studies are needed to clarify the appropriate surgical approach.

Identifiants

pubmed: 34294578
pii: S1590-8658(21)00365-0
doi: 10.1016/j.dld.2021.06.030
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

490-499

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None

Auteurs

Gianluca M Sampietro (GM)

Division of General and HPB Surgery, ASST Rhodense Rho Memorial Hospital, Milan, Italy. Electronic address: gianluca.sampietro@unimi.it.

Giovanni Maconi (G)

Division of Gastroenterology, ASST Fatebenefratelli Sacco, Milan, Italy; Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy.

Francesco Colombo (F)

Division of General Surgery, ASST Fatebenefratelli Sacco, Milan, Italy.

Dario Dilillo (D)

Children's University Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.

Paolo Fiorina (P)

Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy; Division of Endocrinology, ASST Fatebenefratelli Sacco, Milan, Italy; Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; International Center for S1D, Pediatric Clinical Research Center Fondazione Romeo ed Enrica Invernizzi, Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy.

Francesca D'Addio (F)

Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy; International Center for S1D, Pediatric Clinical Research Center Fondazione Romeo ed Enrica Invernizzi, Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy.

Cristian Loretelli (C)

Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy; International Center for S1D, Pediatric Clinical Research Center Fondazione Romeo ed Enrica Invernizzi, Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy.

Cecilia Mantegazza (C)

Children's University Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.

Manuela Nebuloni (M)

Division of Pathology, ASST Fatebenefratelli Sacco, Milan, Italy.

Fabio Corsi (F)

Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy; Breast Unit, Surgery Department, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.

Gianvincenzo Zuccotti (G)

Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy; Children's University Hospital, ASST Fatebenefratelli Sacco, Milan, Italy; International Center for S1D, Pediatric Clinical Research Center Fondazione Romeo ed Enrica Invernizzi, Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy.

Sandro Ardizzone (S)

Division of Gastroenterology, ASST Fatebenefratelli Sacco, Milan, Italy; Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy.

Alberto Corona (A)

Division of Anesthesiology, ASST Di Valle Camonica, Brescia, Esine, Italy.

Diego Foschi (D)

Department of Biomedical and Clinical Science "Luigi Sacco", University of Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH